Skip to search formSkip to main contentSkip to account menu

cycloguanil

Known as: Chlorguanide Triazine, cycloquanil, 1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,2,5-triazine-2,4-diamine 
National Institutes of Health

Related topics

Related topics

6 relations

Broader (4)

AntimalarialsFolic Acid AntagonistsProguanilTriazines
Cycloguanil:MCnc:Pt:Ser/Plas:Qn

Narrower (1)

cycloguanil hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria
The biguanide metformin is widely prescribed for Type II diabetes and has anti-neoplastic activity in laboratory models. Despite… 
Review
2002
Review
2002
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
Cytochrome P450 2C19 (CYP2C19) is the main (or partial) cause for large differences in the pharmacokinetics of a number of… 
Highly Cited
1998
Highly Cited
1998
Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase.
The lack of suitable antimalarial agents to replace chloroquine and pyrimethamine/sulfadoxine threatens efforts to control the… 
Highly Cited
1997
Highly Cited
1997
Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil.
Increasing resistance of Plasmodium falciparum malaria parasites to chloroquine and the dihydrofolate reductase (DHFR) inhibitors… 
Highly Cited
1997
Highly Cited
1997
Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.
Single and multiple mutations at residues 16, 51, 59, 108, and 164 of Plasmodium falciparum dihydrofolate reductase (pfDHFR) have… 
Review
1997
Review
1997
32 bp CCR-5 gene deletion and resistance to fast progression in HIV-1 infected heterozygotes
Highly Cited
1990
Highly Cited
1990
Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
Proguanil and pyrimethamine are antifolate drugs with distinct chemical structures that are used commonly in the prophylaxis and… 
Highly Cited
1990
Highly Cited
1990
Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance.
Cycloguanil, the active metabolite of the antimalarial drug proguanil, is an inhibitor of dihydrofolate reductase as is another… 
Highly Cited
1987
Highly Cited
1987
The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice.
Highly Cited
1980
Highly Cited
1980
The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action.
A series of N-benzyloxydihydrotriazines were prepared and found to have antimalarial activity against Plasmodium berghei… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License